AU2023236844A1 - Lipid monomers for therapeutic delivery of rna - Google Patents

Lipid monomers for therapeutic delivery of rna Download PDF

Info

Publication number
AU2023236844A1
AU2023236844A1 AU2023236844A AU2023236844A AU2023236844A1 AU 2023236844 A1 AU2023236844 A1 AU 2023236844A1 AU 2023236844 A AU2023236844 A AU 2023236844A AU 2023236844 A AU2023236844 A AU 2023236844A AU 2023236844 A1 AU2023236844 A1 AU 2023236844A1
Authority
AU
Australia
Prior art keywords
compound
mmol
oligonucleotide
alkyl
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023236844A
Other languages
English (en)
Inventor
Yi Jin
Marija Prhavc
Mahesh Ramaseshan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of AU2023236844A1 publication Critical patent/AU2023236844A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2023236844A 2022-03-16 2023-03-15 Lipid monomers for therapeutic delivery of rna Pending AU2023236844A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263320689P 2022-03-16 2022-03-16
US63/320,689 2022-03-16
PCT/IB2023/052532 WO2023175536A1 (en) 2022-03-16 2023-03-15 Lipid monomers for therapeutic delivery of rna

Publications (1)

Publication Number Publication Date
AU2023236844A1 true AU2023236844A1 (en) 2024-10-31

Family

ID=85781906

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023236844A Pending AU2023236844A1 (en) 2022-03-16 2023-03-15 Lipid monomers for therapeutic delivery of rna

Country Status (7)

Country Link
JP (1) JP2025509605A (https=)
KR (1) KR20240164787A (https=)
CN (1) CN119213004A (https=)
AU (1) AU2023236844A1 (https=)
CA (1) CA3255238A1 (https=)
MX (1) MX2024011339A (https=)
WO (1) WO2023175536A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025541262A (ja) * 2022-12-13 2025-12-18 上海拓界生物医薬科技有限公司 親油性モノマーを含むオリゴヌクレオチド及びその非肝臓送達における使用
AU2024351190A1 (en) * 2023-09-26 2026-03-26 Tuojie Biotech (Shanghai) Co., Ltd. Lipid-modified nucleic acid compound, and preparation method and use therefor
WO2025261376A1 (zh) * 2024-06-21 2025-12-26 北京炫景瑞医药科技有限公司 肝外递送配体及其缀合物
WO2026046355A1 (zh) * 2024-08-31 2026-03-05 齐鲁制药有限公司 dsRNA分子、药物组合物及其在肝外递送中的应用
CN119241620B (zh) * 2024-12-03 2025-04-08 羿美诚健(上海)生物医药有限公司 一种双链siRNA及其制备方法，药物组合物和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3368933D1 (en) * 1982-09-21 1987-02-12 Fujisawa Pharmaceutical Co Phosphate derivatives, process for preparation thereof and pharmaceutical compositions of the same
EP3983077A4 (en) * 2019-06-17 2023-12-20 Alnylam Pharmaceuticals, Inc. DELIVERY OF OLIGONUCLEOTIDES TO THE STRIATUM
KR20230061389A (ko) * 2020-08-04 2023-05-08 다이서나 파마수이티컬, 인크. 올리고뉴클레오티드의 전신 전달

Also Published As

Publication number Publication date
CA3255238A1 (en) 2023-09-21
JP2025509605A (ja) 2025-04-11
WO2023175536A1 (en) 2023-09-21
MX2024011339A (es) 2024-12-06
KR20240164787A (ko) 2024-11-20
CN119213004A (zh) 2024-12-27

Similar Documents

Publication Publication Date Title
AU2023236844A1 (en) Lipid monomers for therapeutic delivery of rna
EP3458464A1 (en) Stereoselective synthesis of phosphorothioate oligoribonucleotides
AU2021321289A1 (en) Systemic delivery of oligonucleotides
JP7263236B2 (ja) 新規二環式ヌクレオシドおよびそれから調製されたオリゴマー
KR20180103166A (ko) 핵산 복합체
JP7304811B2 (ja) 修飾核酸モノマー化合物及びオリゴ核酸類縁体
KR20210008369A (ko) 7'-5'-알파-아노머-이중고리상 당 뉴클레오시드를 포함하는 올리고뉴클레오티드 컨쥬게이트
CN112759620A (zh) 肝靶向化合物及寡核苷酸缀合物
JP7016170B2 (ja) ヌクレオシド誘導体及びその利用
CN116615542A (zh) 寡核苷酸的全身递送
CN115298192A (zh) 4′-o-亚甲基膦酸酯核酸及其类似物
TWI892530B (zh) 化合物、綴合物、組合物以及其用途
CN115151555B (zh) 桥连型核苷和使用了该桥连型核苷的核苷酸
JP2024508780A (ja) オリゴヌクレオチドおよび炭水化物をコンジュゲートするための組成物
JP7709690B2 (ja) 架橋型ヌクレオシドおよびそれを用いたヌクレオチド
CN120904263B (zh) 具有增加寡核苷酸体内稳定性的2'核糖修饰的核苷酸化合物及其合成方法与应用
CN113490742A (zh) 膦酰基乙酸酯缺口聚物寡核苷酸
CN119528797B (zh) 用于递送治疗的脂质化合物、寡核苷酸递送系统及其制备方法和应用
CA3272530A1 (en) Compound, conjugate, composition, and uses thereof
HK40121892A (en) Compound, conjugate, composition, and uses thereof
CN121358748A (zh) 包含糖的寡核苷酸递送配体
WO2026046355A1 (zh) dsRNA分子、药物组合物及其在肝外递送中的应用
HK40060208A (en) Phosphonoacetate gapmer oligonucleotides
CA3129646A1 (en) Novel phosphoramidites